Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-12 · accession 0001780662-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-14 | 2026-01-12 | ADPT | PISKEL KYLE | CFO | M - OptEx | $12.14 | +4,290 | 220.9K | +2% | +$52.1K |
| D | 2026-01-14 | 2026-01-12 | ADPT | PISKEL KYLE | CFO | S - Sale+OE | $18.00 | -4,290 | 216.6K | -2% | -$77.2K |
| D | 2026-01-14 | 2026-01-12 | ADPT | PISKEL KYLE | CFO | M - OptEx | $0.00 | -4,290 | 4,291 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | M | A | 4,290 | $12.14 | 220,927 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-12 | S | D | 4,290 | $18.00 | 216,637 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-01-12 | M | D | 4,290 | $0.00 | 4,291 | D | $12.14 · — to 2032-03-04 | 4,290 Common Stock | (F2) The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |